Pediatric Prehospital Airway Resuscitation Trial
Key facts
- Who runs it
- Ohio State University
- Where
- Aurora, Austin, Charlotte, Columbus, Indianapolis, Los Angeles, Milwaukee, Sacramento, Tucson, and Washington D.C., United StatesSee the 10 sites
- Trial code
- Status
- Suspended
- People taking part
- 3,000 people, planned
- Started
- 20 May 2024
- Expected to end
- 30 Sept 2029
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- BVM
- SGA
- ETI
- Record updated
- 7 April 2026
- Why it stopped
- Enrollment in Stage I paused due to operational futility.
Who can take part
- Age
- 24 hours to 17 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- At least 24 hours old and <18 years old
- Cardiopulmonary arrest, major trauma or respiratory failure
- Life-saving care initiated or continued by Pedi-PART EMS personnel as part of an emergency "9-1-1" response
- Requiring active airway management (BVM or higher level of respiratory support
Who cannot take part
- Interfacility transports; EMS personnel will use bystander reports or follow local protocols to establish patient age and pregnancy status
- Prisoners
- Pre-existing tracheostomy
- Pre-existing do-not-resuscitate/do-not-intubate status
- Visibly or known to be pregnant
- Initial advanced airway attempt by an EMS agency not affiliated with the study
Where in United States
- University of ColordaoAurora, United States
- Dell Medical School, University of Texas at AustinAustin, United States
- Mecklenburg County Emergency Medical ServicesCharlotte, United States
- Nationwide Children's HospitalColumbus, United States
- Indiana UniversityIndianapolis, United States
- Harbor-University of California Los Angeles Medical CenterLos Angeles, United States
- Medical College of WisconsinMilwaukee, United States
- University of California - DavisSacramento, United States
- University of AirzonaTucson, United States
- Children's National HospitalWashington D.C., United States
About the trial
What the trial wants to find out
This study is a Phase 3, multi-center, Bayesian Adaptive Sequential Platform Trial testing the effectiveness of different prehospital airway management strategies in the care of critically ill children. Emergency Medical Services (EMS) agencies affiliated with the Pediatric Emergency Care Applied Research Network (PECARN) will participate in the trial. The study interventions are strategies of prehospital airway management: [BVM-only], [BVM followed by SGA] and [BVM followed by ETI]. The primary outcome is 30-day ICU-free survival. The trial will be organized and executed in two successive stages. In Stage I of the trial, EMS personnel will alternate between two strategies: [BVM-only] or [BVM followed by SGA]. The [winner of Stage I] will advance to Stage II based upon results of Bayesian interim analyses. In Stage II of the trial, EMS personnel will alternate between [BVM followed by ETI] vs. [Winner of Stage I].
The 3 groups in the trial
- BVM-onlyExisting treatment, for comparison
Initial strategy of airway management using Bag-Valve-Mask (BVM) only.
Treatment: BVM
- BVM followed by SGA [BVM+SGA]Existing treatment, for comparison
Initial strategy of airway management using Bag-Valve-Mask (BVM) followed by Supraglottic Airway (SGA).
Treatment: BVM and SGA
- BVM followed by ETI [BVM+ETI]Existing treatment, for comparison
Initial strategy of airway management using Bag-Valve-Mask (BVM) followed by Endotracheal Intubation (ETI).
Treatment: BVM and ETI
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 7 April 2026